News

NCP4Industry: 2nd round of the Proposal Idea check and Long Term Matchmaking

Published on | 3 years ago

Programmes
Digital, Industry & Space

Services provided by the NCP4Industry network to Stakeholders intending to participate to the next Horizon Europe Industry calls (Destinations 1 and 2 of Cluster 4).

  1. The network has run the Long Term Matchmaking as the continuous service of the Horizon Europe - Industry 2023 Brokerage event, held 14 Dec 2022. Both, already registered participants and new to this event have the opportunity to meet future partners of their proposals under preparation to 2023 Horizon Europe Industry calls (Destinations 1 and 2 of Cluster 4). The Long Term Matchmaking is available until 31 March 2023 at  https://he-industry-2023-brokerage.b2match.io/ .

  2. The NCP4Industry network also opens the second round of Proposal Idea Check service. The network invites researchers, entrepreneurs and other stakeholders to submit their Proposal Ideas addressing one of the industry topics under Destinations 1 & 2 (Cluster 4) to get support and feedbacks from National Contact Points.  The project ideas can be submitted through the NCP4Industry website (the deadline for submission in this round is 13 March 2023): https://ncp4industry.eu/proposal-idea-check/ .

 

Some useful links:

Find NCP4industry on the social media:

myOverview - sign up for personalised information

We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).

Stay informed about what matters to you. By signing up, you can opt in for e-mail notifications and get access to a personalised dashboard that groups all news updates and event announcements in your domain(s).

Only for stakeholders located in Flanders

Latest News

1865 articles available search in articles 

Testimonial

Methylomic – Hope & Improved outcomes for Crohn’s disease patients across Europe

The METHYLOMIC project, ‘targeting hope for personalised medicine in immune-mediated inflammatory diseases’ obtained funding from Horizon Europe’s Health Cluster. The project aims to personalise treatment allocation and enhance the effectiveness of medications for chronic immune-mediated diseases such as Crohn’s disease, rheumatoid arthritis, and psoriasis. BIRD, the Belgian inflammatory bowel disease research and development group, is a partner in the project and is involved in the OmiCrohn trial, a prospective randomised clinical trial for individualised therapy in Crohn’s disease patients. With BIRD’s active role in this trial, the project is set to deliver predictive, biomarker-based therapies that bring renewed hope for Crohn’s disease patients across Europe.